How should intra‑operative hypertension be treated in a patient with a newly transplanted heart?

Management of Intraoperative Hypertension in the Transplanted Heart

Treat intraoperative hypertension in the newly transplanted heart cautiously with titratable intravenous agents, prioritizing avoidance of hypotension over aggressive blood pressure reduction, as hypotension causes more harm than moderate hypertension in this setting.

Critical Principle: Avoid Hypotension Above All

• Maintain mean arterial pressure ≥60 mmHg and systolic blood pressure ≥90 mmHg during any treatment of hypertension, as hypotension is associated with myocardial injury, acute kidney injury, and increased mortality 1
• The transplanted heart is denervated and lacks normal autonomic reflexes, making it particularly vulnerable to hypotensive episodes that can compromise graft perfusion 2, 3
• When treating intraoperative hypertension, do so carefully to avoid inducing hypotension, as the harm from hypotension exceeds the risk of moderate hypertension 1

First-Line Pharmacologic Management

Preferred Agent: Clevidipine

• Clevidipine is the most effective intravenous antihypertensive for perioperative hypertension in cardiac surgery patients, demonstrating superior efficacy compared to other agents in meta-analyses 1
• Start at 1-2 mg/hour and titrate upward in doubling increments every 90 seconds as tolerated, up to 16 mg/hour, then increase by 7 mg/hour increments if needed 4
• Blood pressure reduction occurs within 2-4 minutes, allowing precise titration 4
• The ultra-short half-life (approximately 1 minute) provides excellent control and rapid reversibility if hypotension develops 4

Alternative Agent: Nicardipine

• Nicardipine is an effective alternative when clevidipine is unavailable, achieving therapeutic response in approximately 12 minutes 5
• Begin at 5 mg/hour and increase by 2.5 mg/hour every 15 minutes up to a maximum of 15 mg/hour 6
• Provides controlled, titratable blood pressure reduction comparable to sodium nitroprusside without cyanide toxicity risk 5

Avoid Beta-Blockers and Labetalol

• Do not use labetalol or pure beta-blockers in the denervated transplanted heart, as the transplanted heart depends on circulating catecholamines for chronotropic and inotropic support due to loss of sympathetic innervation 2, 3
• Beta-blockade can precipitate severe bradycardia and reduced cardiac output in this population 2

Target Blood Pressure Parameters

• Aim for blood pressure approximately 10% above the patient's baseline rather than aggressive normalization 6, 5
• For patients with chronic hypertension pre-transplant, maintain blood pressure within 10% of their usual baseline 6
• Avoid systolic blood pressure <90 mmHg and mean arterial pressure <60 mmHg at all times during treatment 1

Address Reversible Causes First

• Evaluate and treat pain, hypoxia, bladder distention, and volume overload before initiating or escalating intravenous antihypertensives 1, 6
• Inadequate analgesia is a primary driver of postoperative hypertension and should be optimized first 6, 5
• Assess oxygenation and correct hypoxia, which stimulates sympathetic activity 5

Long-Term Considerations for Transplant Recipients

• Calcium channel blockers are the preferred long-term antihypertensive agents in heart transplant recipients and should be continued perioperatively 2
• ACE inhibitors and ARBs can be used as second-line agents and may provide renal protection against calcineurin-inhibitor nephropathy 2
• Hypertension affects >95% of cardiac transplant recipients, making effective blood pressure control essential to prevent left ventricular remodeling, diastolic dysfunction, and stroke 2, 3

Critical Pitfalls to Avoid

• Never initiate beta-blockers intraoperatively in the transplanted heart due to denervation 2
• Avoid over-aggressive blood pressure reduction, as the transplanted heart cannot compensate for sudden drops in preload or afterload through normal autonomic mechanisms 1, 2
• Do not use agents that rely on intact baroreceptor reflexes for safe titration 3
• Recognize that the denervated heart has elevated systemic vascular resistance and depends on adequate preload and afterload for optimal function 7